MedAdvisor Limited (ASX:MDR) Provides Strategic Review Update
MedAdvisor Limited (ASX:MDR) announces a strategic review update, detailing a potential $35 million sale of its ANZ business division to a major software firm.
MedAdvisor Limited
MedAdvisor Limited (ASX:MDR) announces a strategic review update, detailing a potential $35 million sale of its ANZ business division to a major software firm.
MedAdvisor Limited (ASX:MDR) places trading halt pending strategic acquisition proposal of ANZ business division.
MedAdvisor Limited (ASX:MDR) receives a non-binding LOI to sell its ANZ division, reflecting a higher value than current share price.
MedAdvisor Limited (ASX:MDR) reports a significant decrease in 3Q FY25 revenue, announces cost-cutting measures and strategic initiatives.